Scripps MD Anderson Cancer Center

https://www.Scripps.org/HemOncCME

 

Neoadjuvant IO and Targeted Therapy for Advanced Resectable Melanoma: The Ability to Achieve pCR Correlates With Improved RFS

271 views
March 9, 2020
0 Comments
Login to view comments. Click here to Login
Diagnosis and Management of Melanoma